[Measurement of rifampicin and clarithromycin in serum by high-performance liquid chromatography with electrochemical detection].
Rifampicin (RFP) induces hepatic drug-metabolizing enzymes, making drug interactions a very important clinical problem. Clarithromycin (CAM) metabolism is reportedly enhanced by induction of hepatic drug-metabolizing enzymes (CYP3A4) by RFP, so that the blood lend of CAM decreases when RFP is administered concurrently. We connected an electrochemical detector to a high-performance liquid chromatograph (HPLC) for simple, rapid, easy measurement of blood concentrations of RFP and CAM. Using samples of patient serum, normal serum, and reference standards, we compared HPLC by an external laboratory and the results of LC/MS/MS analysis with those of this new assay. A strong correlation was seen between our HPLC results and those of the external laboratory in RFP levels (r=0.975, p<0.01). A strong correlation was also seen between results we obtained for CAM with the electrochemical detector in this assay and values measured by LC/MS/MS analysis (r=0.995, p<0.01). Our method enabled simple, rapid measurement of RFP and CAM by connecting the HPLC and electrochemical detector in tandem. This system was used to modulate dosage during combined therapy with RFP and CAM. The therapeutic effect for nontuberculous mycobacteriosis is expected to improve, and our HPLC is expected to be useful for simple, rapid, easy measurement of blood concentrations.
Taki
Hisashi
H
Department of Pharmacy, National Hospital Organization Higashi Nagoya National Hospital.
Ogawa
Kenji
K
Nakagawa
Taku
T
Nikai
Toshiaki
T
D000368:Aged; D002851:Chromatography, High Pressure Liquid; D017291:Clarithromycin / Q000097:blood*; D004563:Electrochemistry; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism; D012293:Rifampin / Q000097:blood*
D017291:Clarithromycin; D012293:Rifampin